Australia markets closed

AFT Pharmaceuticals Limited (AFP.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
4.5600-0.1200 (-2.56%)
At close: 3:12PM AEDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2021
31/03/2020
31/03/2019
31/03/2018
Total revenue
119,668
113,105
105,597
85,127
79,882
Cost of revenue
64,683
64,364
57,332
44,397
45,880
Gross profit
54,985
48,741
48,265
40,730
34,002
Operating expenses
Research development
4,410
3,437
1,984
2,588
8,230
Selling general and administrative
37,446
35,222
35,314
33,742
36,841
Total operating expenses
42,952
39,763
38,079
36,649
45,411
Operating income or loss
12,033
8,978
10,186
4,081
-11,409
Interest expense
3,484
3,441
8,052
8,417
2,652
Total other income/expenses net
1,264
1,242
10,239
1,716
930
Income before tax
11,090
7,887
12,877
-2,259
-12,666
Income tax expense
257
105
185
168
58
Income from continuing operations
10,833
7,782
12,692
-2,427
-12,724
Net income
10,833
7,782
12,692
-2,427
-12,724
Net income available to common shareholders
10,833
7,782
12,692
-2,427
-13,136
Basic EPS
-
0.08
0.13
-0.02
-0.13
Diluted EPS
-
0.08
0.13
-0.02
-0.13
Basic average shares
-
103,297
97,309
97,308
97,249
Diluted average shares
-
103,297
97,309
97,308
97,249
EBITDA
-
12,432
21,710
6,477
-9,674